We are live on ! Find out more
JGIA

Jackson Grant Investment Advisers Portfolio holdings

AUM $322M
1-Year Est. Return 20.03%
This Fund
S&P 500
This Quarter Est. Return
+9.86%
1 Year Est. Return
+20.03%
3 Year Est. Return
+54.33%
5 Year Est. Return
+61.8%
10 Year Est. Return
+185.98%
AUM
$207M
AUM Growth
+$15.8M
Cap. Flow
-$1.36M
Cap. Flow %
-0.66%
Top 10 Hldgs %
53.64%
Holding
348
New
3
Increased
111
Reduced
39
Closed
33

Sector Composition

Rank Sector Weight
1 Healthcare 7.18%
2 Technology 5.71%
3 Consumer Staples 4.77%
4 Industrials 2.69%
5 Consumer Discretionary 2.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBM icon
51
IBM
IBM
$221B
$700K 0.34%
4,972
+11
+0.2% +$1.52K
SHY icon
52
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$692K 0.33%
8,529
-6,577
-44% -$534K
PFE icon
53
Pfizer
PFE
$150B
$596K 0.29%
11,636
+31
+0.3% +$1.49K
AMGN icon
54
Amgen
AMGN
$226B
$590K 0.29%
2,246
SPTM icon
55
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.1B
$584K 0.28%
12,355
+130
+1% +$6.18K
DIS icon
56
Walt Disney
DIS
$178B
$583K 0.28%
6,715
+469
+8% +$44.9K
SPYG icon
57
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$55.2B
$545K 0.26%
10,747
+29
+0.3% +$1.51K
IWC icon
58
iShares Micro-Cap ETF
IWC
$1.5B
$529K 0.26%
4,905
-442
-8% -$48.1K
NEE icon
59
NextEra Energy
NEE
$178B
$519K 0.25%
6,203
+1
+0% +$81
VYM icon
60
Vanguard High Dividend Yield ETF
VYM
$83.9B
$504K 0.24%
4,656
-17
-0.4% -$1.81K
CL icon
61
Colgate-Palmolive
CL
$74B
$501K 0.24%
6,360
+27
+0.4% +$2.02K
BMY icon
62
Bristol-Myers Squibb
BMY
$130B
$470K 0.23%
6,533
+5
+0.1% +$377
IVE icon
63
iShares S&P 500 Value ETF
IVE
$49.9B
$469K 0.23%
3,233
+18
+0.6% +$2.57K
GLD icon
64
SPDR Gold Trust
GLD
$144B
$460K 0.22%
2,709
+91
+3% +$14.7K
T icon
65
AT&T
T
$166B
$447K 0.22%
24,297
-2,566
-10% -$45.9K
TRI icon
66
Thomson Reuters
TRI
$43.9B
$434K 0.21%
3,609
HD icon
67
Home Depot
HD
$346B
$424K 0.2%
1,341
+1
+0.1% +$305
IVW icon
68
iShares S&P 500 Growth ETF
IVW
$77.3B
$401K 0.19%
6,861
+15
+0.2% +$901
VGT icon
69
Vanguard Information Technology ETF
VGT
$149B
$384K 0.19%
9,616
-528
-5% -$21.5K
BDJ icon
70
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.75B
$382K 0.18%
42,376
+1,003
+2% +$8.87K
GOOGL icon
71
Alphabet (Google) Class A
GOOGL
$4.17T
$367K 0.18%
4,160
+40
+1% +$3.8K
QQQ icon
72
Invesco QQQ Trust
QQQ
$482B
$363K 0.18%
1,364
-266
-16% -$73.6K
V icon
73
Visa
V
$670B
$359K 0.17%
1,727
JPM icon
74
JPMorgan Chase
JPM
$969B
$357K 0.17%
2,665
+4
+0.2% +$507
BXMX
75
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$343K 0.17%
27,110
+362
+1% +$4.67K

Similar funds

Jackson Grant Investment Advisers's Q4 2022 Portfolio in Review

As of Q4 2022, Jackson Grant Investment Advisers held 348 positions worth $207M, up 8.3% from $191M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Jackson Grant Investment Advisers's Q4 2022 filing shows 3 new, 111 increased, 39 reduced and 33 closed positions. Its largest new stake was Diageo: 929 shares worth $166K. The largest sale was iShares Core US Aggregate Bond ETF, an estimated $1.85M.

By sector, the portfolio is most concentrated in Healthcare at 7.2% of assets, up from 6.8% a quarter earlier, followed by Technology and Consumer Staples.

  • Jackson Grant Investment Advisers's largest Q4 2022 buy was Diageo: 929 shares worth $166K.
  • Jackson Grant Investment Advisers added most to State Street SPDR Portfolio S&P 500 ETF in Q4 2022, an estimated $3.85M increase.
  • Jackson Grant Investment Advisers's biggest Q4 2022 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $1.85M.
  • Jackson Grant Investment Advisers fully exited LiveRamp in Q4 2022, selling an estimated $61K.
  • Jackson Grant Investment Advisers's ten largest holdings make up 54% of its $207M portfolio in Q4 2022.
  • Jackson Grant Investment Advisers opened 3 new positions and closed 33 in Q4 2022.
  • Jackson Grant Investment Advisers's portfolio value rose 8.3% quarter-over-quarter to $207M.

Based on Jackson Grant Investment Advisers's 13F filing for Q4 2022, filed 26 Jan 2023.